BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 502003)

  • 1. [Clinical and experimental studies of the influence of Cl-inactivator on the euglobulin clot lysis time (author's transl)].
    Takeda S; Katoh H; Takaki A; Nouzuka Y; Ohsato K
    Rinsho Ketsueki; 1979 Aug; 20(8):879-85. PubMed ID: 502003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the ratio of the euglobulin clot lysis time and fibrinogen content in euglobulin (author's transl)].
    Matsuo T; Matsunaga K
    Rinsho Ketsueki; 1974 Oct; 15(10):1128-32. PubMed ID: 4476809
    [No Abstract]   [Full Text] [Related]  

  • 3. C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis.
    Kluft C
    Thromb Res; 1978 Aug; 13(2):135-51. PubMed ID: 694838
    [No Abstract]   [Full Text] [Related]  

  • 4. Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity.
    Kluft C
    Haemostasis; 1976; 5(3):136-46. PubMed ID: 12071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimation upon euglobulin clot lysis time, fibrin plate methods, and their clinical value (author's transl)].
    Fujita S
    Rinsho Byori; 1974 Aug; 22(8):539-44. PubMed ID: 4473623
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolysis: studies on the significance of euglobulin clot lysis time and re-examination of its estimation method].
    Ishii S; Kimura T; Numakami A; Ito S; Azumagawa T; Kikuchi N
    Kanagawa Shigaku; 1985 Sep; 20(2):271-81. PubMed ID: 3869263
    [No Abstract]   [Full Text] [Related]  

  • 7. [An evaluation of euglobulin clot lysis time (ELT) measurement with the time saving recorder (author's transl)].
    Amemiya Y; Amaki I; Ariga T; Sawai H; Oshiba S
    Rinsho Ketsueki; 1973 Oct; 14(10):1008-17. PubMed ID: 4796985
    [No Abstract]   [Full Text] [Related]  

  • 8. [The studies on the method of euglulin clot lysis time using acid-treated euglobulin (author's transl)].
    Yasukouchi T; Yoshida S; Watanabe T; Fujine M; Kohn S; Morioka T; Sakurama S; Nakagawa S
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):553-8. PubMed ID: 696195
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on C1 inactivator resistant fibrinolytic activity].
    Deguchi A; Kawamura K; Deguchi K; Tamaki S; Tanigawa M; Iwasaki E; Wada H; Murashima S; Nishikawa M; Shirakawa S
    Rinsho Byori; 1991 May; 39(5):517-22. PubMed ID: 2072575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunochemical studies on proteinase inhibitor of co-precipitation after euglobulin fraction of plasma (author's transl)].
    Miyatani K
    Rinsho Byori; 1979; 27(1):57-9. PubMed ID: 311865
    [No Abstract]   [Full Text] [Related]  

  • 11. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.
    Urano T; Sumiyoshi K; Pietraszek MH; Takada Y; Takada A
    Thromb Haemost; 1991 Oct; 66(4):474-8. PubMed ID: 1796399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator.
    Kluft C
    Haemostasis; 1977; 6(6):351-69. PubMed ID: 611048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of euglobulin methods for the study of blood fibrinolytic activity: results for patients with rheumatoid arthritis and in the postoperative period.
    Kluft C; Cooper P; Jie AF; Lowe GD; Forbes CD; Blamey SL; van de Putte LB
    Haemostasis; 1985; 15(2):144-50. PubMed ID: 3874124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ingestion of glucose on fibrinolytic activity and prothrombin time in diabetic and non-diabetic persons.
    Joshi VD
    Indian J Physiol Pharmacol; 1979; 23(2):127-32. PubMed ID: 489094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Euglobulin lysis time method (author's transl)].
    Kazama M
    Rinsho Byori; 1976 Apr; 24(4):316-20. PubMed ID: 132550
    [No Abstract]   [Full Text] [Related]  

  • 16. Euglobulin lysis time in fresh and stored samples.
    Prisco D; Paniccia R; Bandinelli B; Filippini M; Brunelli T; Zarone N; Francalanci I; Abbate R
    Am J Clin Pathol; 1994 Dec; 102(6):794-6. PubMed ID: 7801893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis.
    Nordby E; Arnesen H; Andersen P; Godal HC
    Scand J Haematol; 1980 Nov; 25(5):407-11. PubMed ID: 7221476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clotting-fibrinolytic system and complements (author's transl)].
    Nagaki K; Inai S
    Rinsho Byori; 1978; 26(4):282-4. PubMed ID: 671773
    [No Abstract]   [Full Text] [Related]  

  • 19. A new method based on one dimensional diffusion using small glass tubes for the measurement of fibrinolytic activity. I. Fibrinolytic activity of plasmin and "euglobulin + streptokinase".
    Yasukouchi T; Watanabe T
    Thromb Diath Haemorrh; 1972 Dec; 28(3):329-41. PubMed ID: 4265315
    [No Abstract]   [Full Text] [Related]  

  • 20. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.